Faeth Therapeutics, Inc. Common Stock

FTHNASDAQ • USD
28.00 USD
↘ 1.05 (3.61%)AT CLOSE (11:59 AM EDT)
27.30
↘ 0.70 (2.50%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
27.30
↘ 0.70 (2.50%)
🔴Market: CLOSED

Faeth Therapeutics, Inc. Common Stock (FTH) trades at $28.00 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity and a bullish Golden Cross on the moving averages. FTH is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Sep 25, 2026.

Open?$28.93
High?$28.93
Low?$27.60
Prev. Close?$29.05
Volume?328.2K
Avg. Volume?410.2K
VWAP?$28.12
Rel. Volume?0.80x
Bid / Ask
Bid?$16.50 × 500
Ask?$35.00 × 100
Spread?$18.50
Midpoint?$25.75
Valuation & Ratios
Market Cap?723.5M
Shares Out?25.8M
P/E Ratio?N/A
P/B Ratio?4.18
EPS?-$7.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Employees
29
Market Cap
723.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-02-04
Address
701 TILLERY STREET #12 #1010
AUSTIN, TX 78702
Phone: 512-200-2982
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short Interest?1.3M
Days to Cover?4.4
Avg Daily Volume301.8K
Settlement Date2026-09-15
Financial Health
Current Ratio?19.69Strong
Quick Ratio?19.69Strong
Cash Ratio?2.81Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
43
4.18FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-113.1%WEAK▾
ROA?
S&P
3
-103.3%WEAK▾
Cash Flow & Enterprise
FCF?$-33862000
Enterprise Value?$696.6M
Fundamentals ratios updated end of day